August 2012 Issue Table Of Contents

From The Editor

• Diversity In Clinical Trials – A Best Business Practice

Ask The Board

• Ask The Board August 2012

Outsourcing Insights

• To Insource Or Outsource Sterile Injectable Production?

Big Data Points

• Biopharma Outsourcing Leveling Out

Feature

• Africa – The Next Frontier For Novartis Clinical Development
• Novelty, Purity, And Potency: Three Pillars Of Biotherapeutics
• Not-For-Profits Fill The R&D Gap For Underserved Diseases

Inside The Industry

• Direct To Data - An Electronic Solution To Patient Diaries
• Pharmaceutical Supply Chain: The Next Green Frontier
• Why Life Sciences  Needs To Reassess Their U.S. Patent Strategies
• The Slow Progression Of Pharma Regulatory Harmonization
• International Incentives: Are They All They’re Cracked Up To Be?

Industry Leader

• The Impact Of DMPK Clinical Failures
• Preparing For A Successful FDA Inspection
• Raising Life Sciences Capital: An Alternative Way
• Creating New Realities From Vision - The Key To Success For Any Leader